Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 58

1.

Image processing and analysis methods for the Adolescent Brain Cognitive Development Study.

Hagler DJ Jr, Hatton S, Cornejo MD, Makowski C, Fair DA, Dick AS, Sutherland MT, Casey BJ, Barch DM, Harms MP, Watts R, Bjork JM, Garavan HP, Hilmer L, Pung CJ, Sicat CS, Kuperman J, Bartsch H, Xue F, Heitzeg MM, Laird AR, Trinh TT, Gonzalez R, Tapert SF, Riedel MC, Squeglia LM, Hyde LW, Rosenberg MD, Earl EA, Howlett KD, Baker FC, Soules M, Diaz J, de Leon OR, Thompson WK, Neale MC, Herting M, Sowell ER, Alvarez RP, Hawes SW, Sanchez M, Bodurka J, Breslin FJ, Morris AS, Paulus MP, Simmons WK, Polimeni JR, van der Kouwe A, Nencka AS, Gray KM, Pierpaoli C, Matochik JA, Noronha A, Aklin WM, Conway K, Glantz M, Hoffman E, Little R, Lopez M, Pariyadath V, Weiss SR, Wolff-Hughes DL, DelCarmen-Wiggins R, Feldstein Ewing SW, Miranda-Dominguez O, Nagel BJ, Perrone AJ, Sturgeon DT, Goldstone A, Pfefferbaum A, Pohl KM, Prouty D, Uban K, Bookheimer SY, Dapretto M, Galvan A, Bagot K, Giedd J, Infante MA, Jacobus J, Patrick K, Shilling PD, Desikan R, Li Y, Sugrue L, Banich MT, Friedman N, Hewitt JK, Hopfer C, Sakai J, Tanabe J, Cottler LB, Nixon SJ, Chang L, Cloak C, Ernst T, Reeves G, Kennedy DN, Heeringa S, Peltier S, Schulenberg J, Sripada C, Zucker RA, Iacono WG, Luciana M, Calabro FJ, Clark DB, Lewis DA, Luna B, Schirda C, Brima T, Foxe JJ, Freedman EG, Mruzek DW, Mason MJ, Huber R, McGlade E, Prescot A, Renshaw PF, Yurgelun-Todd DA, Allgaier NA, Dumas JA, Ivanova M, Potter A, Florsheim P, Larson C, Lisdahl K, Charness ME, Fuemmeler B, Hettema JM, Maes HH, Steinberg J, Anokhin AP, Glaser P, Heath AC, Madden PA, Baskin-Sommers A, Constable RT, Grant SJ, Dowling GJ, Brown SA, Jernigan TL, Dale AM.

Neuroimage. 2019 Nov 15;202:116091. doi: 10.1016/j.neuroimage.2019.116091. Epub 2019 Aug 12.

PMID:
31415884
2.

The conception of the ABCD study: From substance use to a broad NIH collaboration.

Volkow ND, Koob GF, Croyle RT, Bianchi DW, Gordon JA, Koroshetz WJ, PĂ©rez-Stable EJ, Riley WT, Bloch MH, Conway K, Deeds BG, Dowling GJ, Grant S, Howlett KD, Matochik JA, Morgan GD, Murray MM, Noronha A, Spong CY, Wargo EM, Warren KR, Weiss SRB.

Dev Cogn Neurosci. 2018 Aug;32:4-7. doi: 10.1016/j.dcn.2017.10.002. Epub 2017 Oct 10. Review.

3.

A population-average MRI-based atlas collection of the rhesus macaque.

McLaren DG, Kosmatka KJ, Oakes TR, Kroenke CD, Kohama SG, Matochik JA, Ingram DK, Johnson SC.

Neuroimage. 2009 Mar 1;45(1):52-9. doi: 10.1016/j.neuroimage.2008.10.058. Epub 2008 Nov 14.

4.

Greater nicotinic acetylcholine receptor density in smokers than in nonsmokers: a PET study with 2-18F-FA-85380.

Mukhin AG, Kimes AS, Chefer SI, Matochik JA, Contoreggi CS, Horti AG, Vaupel DB, Pavlova O, Stein EA.

J Nucl Med. 2008 Oct;49(10):1628-35. doi: 10.2967/jnumed.108.050716. Epub 2008 Sep 15.

5.

Quantification of nicotinic acetylcholine receptors in the human brain with PET: bolus plus infusion administration of 2-[18F]F-A85380.

Kimes AS, Chefer SI, Matochik JA, Contoreggi CS, Vaupel DB, Stein EA, Mukhin AG.

Neuroimage. 2008 Jan 15;39(2):717-27. Epub 2007 Sep 19.

6.

Cerebral metabolism and mood in remitted opiate dependence.

Galynker II, Eisenberg D, Matochik JA, Gertmenian-King E, Cohen L, Kimes AS, Contoreggi C, Kurian V, Ernst M, Rosenthal RN, Prosser J, London ED.

Drug Alcohol Depend. 2007 Oct 8;90(2-3):166-74. Epub 2007 May 22.

7.

Estimation of D2-like receptor occupancy by dopamine in the putamen of hemiparkinsonian Monkeys.

Chefer SI, Kimes AS, Matochik JA, Horti AG, Kurian V, Shumway D, Domino EF, London ED, Mukhin AG.

Neuropsychopharmacology. 2008 Jan;33(2):270-8. Epub 2007 Apr 11.

8.

Education-associated cortical glucose metabolism during sustained attention.

Eisenberg DP, London ED, Matochik JA, Derbyshire S, Cohen LJ, Steinfeld M, Prosser J, Galynker II.

Neuroreport. 2005 Sep 8;16(13):1473-6.

9.

Neural substrates of faulty decision-making in abstinent marijuana users.

Bolla KI, Eldreth DA, Matochik JA, Cadet JL.

Neuroimage. 2005 Jun;26(2):480-92. Epub 2005 Mar 23.

PMID:
15907305
10.

Risky decision making and the anterior cingulate cortex in abstinent drug abusers and nonusers.

Fishbein DH, Eldreth DL, Hyde C, Matochik JA, London ED, Contoreggi C, Kurian V, Kimes AS, Breeden A, Grant S.

Brain Res Cogn Brain Res. 2005 Apr;23(1):119-36.

PMID:
15795139
11.

Effect of leptin replacement on brain structure in genetically leptin-deficient adults.

Matochik JA, London ED, Yildiz BO, Ozata M, Caglayan S, DePaoli AM, Wong ML, Licinio J.

J Clin Endocrinol Metab. 2005 May;90(5):2851-4. Epub 2005 Feb 15.

PMID:
15713712
12.

Altered brain tissue composition in heavy marijuana users.

Matochik JA, Eldreth DA, Cadet JL, Bolla KI.

Drug Alcohol Depend. 2005 Jan 7;77(1):23-30.

PMID:
15607838
13.

Abnormal brain activity in prefrontal brain regions in abstinent marijuana users.

Eldreth DA, Matochik JA, Cadet JL, Bolla KI.

Neuroimage. 2004 Nov;23(3):914-20.

PMID:
15528091
14.

Sex-related differences in a gambling task and its neurological correlates.

Bolla KI, Eldreth DA, Matochik JA, Cadet JL.

Cereb Cortex. 2004 Nov;14(11):1226-32. Epub 2004 May 13.

PMID:
15142963
15.

Age-related decline in striatal volume in rhesus monkeys: assessment of long-term calorie restriction.

Matochik JA, Chefer SI, Lane MA, Roth GS, Mattison JA, London ED, Ingram DK.

Neurobiol Aging. 2004 Feb;25(2):193-200.

PMID:
14749137
16.

Mood disturbances and regional cerebral metabolic abnormalities in recently abstinent methamphetamine abusers.

London ED, Simon SL, Berman SM, Mandelkern MA, Lichtman AM, Bramen J, Shinn AK, Miotto K, Learn J, Dong Y, Matochik JA, Kurian V, Newton T, Woods R, Rawson R, Ling W.

Arch Gen Psychiatry. 2004 Jan;61(1):73-84.

PMID:
14706946
17.

Frontal cortical tissue composition in abstinent cocaine abusers: a magnetic resonance imaging study.

Matochik JA, London ED, Eldreth DA, Cadet JL, Bolla KI.

Neuroimage. 2003 Jul;19(3):1095-102.

PMID:
12880835
18.

Orbitofrontal cortex dysfunction in abstinent cocaine abusers performing a decision-making task.

Bolla KI, Eldreth DA, London ED, Kiehl KA, Mouratidis M, Contoreggi C, Matochik JA, Kurian V, Cadet JL, Kimes AS, Funderburk FR, Ernst M.

Neuroimage. 2003 Jul;19(3):1085-94.

19.

Neural substrates of decision making in adults with attention deficit hyperactivity disorder.

Ernst M, Kimes AS, London ED, Matochik JA, Eldreth D, Tata S, Contoreggi C, Leff M, Bolla K.

Am J Psychiatry. 2003 Jun;160(6):1061-70.

PMID:
12777263
20.

2-[18F]F-A-85380: PET imaging of brain nicotinic acetylcholine receptors and whole body distribution in humans.

Kimes AS, Horti AG, London ED, Chefer SI, Contoreggi C, Ernst M, Friello P, Koren AO, Kurian V, Matochik JA, Pavlova O, Vaupel DB, Mukhin AG.

FASEB J. 2003 Jul;17(10):1331-3. Epub 2003 May 20.

PMID:
12759330
21.

Decision-making in a risk-taking task: a PET study.

Ernst M, Bolla K, Mouratidis M, Contoreggi C, Matochik JA, Kurian V, Cadet JL, Kimes AS, London ED.

Neuropsychopharmacology. 2002 May;26(5):682-91.

22.

The effects of ECT on brain glucose: a pilot FDG PET study.

Henry ME, Schmidt ME, Matochik JA, Stoddard EP, Potter WZ.

J ECT. 2001 Mar;17(1):33-40.

PMID:
11281513
23.

Effect of nicotine on brain activation during performance of a working memory task.

Ernst M, Matochik JA, Heishman SJ, Van Horn JD, Jons PH, Henningfield JE, London ED.

Proc Natl Acad Sci U S A. 2001 Apr 10;98(8):4728-33. Epub 2001 Mar 27.

24.

Opioid receptor imaging with positron emission tomography and [(18)F]cyclofoxy in long-term, methadone-treated former heroin addicts.

Kling MA, Carson RE, Borg L, Zametkin A, Matochik JA, Schluger J, Herscovitch P, Rice KC, Ho A, Eckelman WC, Kreek MJ.

J Pharmacol Exp Ther. 2000 Dec;295(3):1070-6.

PMID:
11082442
25.

Age-related decline in striatal volume in monkeys as measured by magnetic resonance imaging.

Matochik JA, Chefer SI, Lane MA, Woolf RI, Morris ED, Ingram DK, Roth GS, London ED.

Neurobiol Aging. 2000 Jul-Aug;21(4):591-8.

PMID:
10924777
26.

Adrenergic and noradrenergic plasma levels in Lesch-Nyhan disease.

Ernst M, Zametkin AJ, Pascualvaca D, Matochik JA, Eisenhofer G, Murphy DL, Cohen RM.

Neuropsychopharmacology. 2000 Mar;22(3):320-6.

27.

High midbrain [18F]DOPA accumulation in children with attention deficit hyperactivity disorder.

Ernst M, Zametkin AJ, Matochik JA, Pascualvaca D, Jons PH, Cohen RM.

Am J Psychiatry. 1999 Aug;156(8):1209-15.

PMID:
10450262
28.

Loss of D2 receptor binding with age in rhesus monkeys: importance of correction for differences in striatal size.

Morris ED, Chefer SI, Lane MA, Muzic RF Jr, Wong DF, Dannals RF, Matochik JA, Bonab AA, Villemagne VL, Grant SJ, Ingram DK, Roth GS, London ED.

J Cereb Blood Flow Metab. 1999 Feb;19(2):218-29.

PMID:
10027777
29.

High presynaptic dopaminergic activity in children with Tourette's disorder.

Ernst M, Zametkin AJ, Jons PH, Matochik JA, Pascualvaca D, Cohen RM.

J Am Acad Child Adolesc Psychiatry. 1999 Jan;38(1):86-94.

PMID:
9893421
30.
31.

Smaller volume of prefrontal lobe in polysubstance abusers: a magnetic resonance imaging study.

Liu X, Matochik JA, Cadet JL, London ED.

Neuropsychopharmacology. 1998 Apr;18(4):243-52.

32.

Low medial prefrontal dopaminergic activity in autistic children.

Ernst M, Zametkin AJ, Matochik JA, Pascualvaca D, Cohen RM.

Lancet. 1997 Aug 30;350(9078):638. No abstract available. Erratum in: Lancet 1998 Feb 7;351(9100):454.

PMID:
9288051
33.

Gender differences in brain metabolic and plasma catecholamine responses to alpha 2-adrenoceptor blockade.

Schmidt ME, Matochik JA, Goldstein DS, Schouten JL, Zametkin AJ, Potter WZ.

Neuropsychopharmacology. 1997 Apr;16(4):298-310.

34.

Acute alpha 2 blockade by idazoxan increases insulin and lowers plasma glucose during positron emission tomography.

Schmidt ME, Goldstein DS, Schouten JL, Matochik JA, Kim HG, Potter WZ.

Psychopharmacol Bull. 1997;33(2):253-9.

PMID:
9230639
35.

Cerebral glucose metabolism during pharmacologic studies: test-retest under placebo conditions.

Schmidt ME, Ernst M, Matochik JA, Maisog JM, Pan BS, Zametkin AJ, Potter WZ.

J Nucl Med. 1996 Jul;37(7):1142-9.

36.

Presynaptic dopaminergic deficits in Lesch-Nyhan disease.

Ernst M, Zametkin AJ, Matochik JA, Pascualvaca D, Jons PH, Hardy K, Hankerson JG, Doudet DJ, Cohen RM.

N Engl J Med. 1996 Jun 13;334(24):1568-72.

37.

Abnormalities in sustained attention and anterior cingulate metabolism in subjects with resistance to thyroid hormone.

Matochik JA, Zametkin AJ, Cohen RM, Hauser P, Weintraub BD.

Brain Res. 1996 Jun 3;723(1-2):23-8.

PMID:
8813378
38.

Regional brain glucose metabolism after acute alpha 2-blockade by idazoxan.

Schmidt ME, Matochik JA, Risinger RC, Schouten JL, Zametkin AJ, Cohen RM, Potter WZ.

Clin Pharmacol Ther. 1995 Jun;57(6):684-95.

PMID:
7781269
39.

Regional cerebral glucose metabolism in autopsy-confirmed Creutzfeldt-Jakob disease.

Matochik JA, Molchan SE, Zametkin AJ, Warden DL, Sunderland T, Cohen RM.

Acta Neurol Scand. 1995 Feb;91(2):153-7.

PMID:
7785428
40.

ADHD and the thyroid controversy.

Hauser P, Zametkin AJ, Martinez P, Vitiello B, Matochik JA, Mixson AJ, Weintraub BD.

J Am Acad Child Adolesc Psychiatry. 1994 Jun;33(5):756-8. No abstract available.

PMID:
8056740
41.

Cerebral glucose metabolism in adults with attention deficit hyperactivity disorder after chronic stimulant treatment.

Matochik JA, Liebenauer LL, King AC, Szymanski HV, Cohen RM, Zametkin AJ.

Am J Psychiatry. 1994 May;151(5):658-64.

PMID:
8166305
42.

A double FDG/PET study of the effects of scopolamine in older adults.

Molchan SE, Matochik JA, Zametkin AJ, Szymanski HV, Cantillon M, Cohen RM, Sunderland T.

Neuropsychopharmacology. 1994 May;10(3):191-8.

43.
44.

Intracranial androgenic activation of male-typical behaviors in house mice: motivation versus performance.

Matochik JA, Sipos ML, Nyby JG, Barfield RJ.

Behav Brain Res. 1994 Feb 28;60(2):141-9.

PMID:
8003244
45.

Effects of intravenous dextroamphetamine on brain metabolism in adults with attention-deficit hyperactivity disorder (ADHD). Preliminary findings.

Ernst M, Zametkin AJ, Matochik JA, Liebenauer L, Fitzgerald GA, Cohen RM.

Psychopharmacol Bull. 1994;30(2):219-25.

PMID:
7831459
46.

Effects of acute stimulant medication on cerebral metabolism in adults with hyperactivity.

Matochik JA, Nordahl TE, Gross M, Semple WE, King AC, Cohen RM, Zametkin AJ.

Neuropsychopharmacology. 1993 Jun;8(4):377-86.

47.

Attention deficit-hyperactivity disorder in people with generalized resistance to thyroid hormone.

Hauser P, Zametkin AJ, Martinez P, Vitiello B, Matochik JA, Mixson AJ, Weintraub BD.

N Engl J Med. 1993 Apr 8;328(14):997-1001.

48.

Regulation of sociosexual communication in female Long-Evans rats by ovarian hormones.

Matochik JA, Barfield RJ, Nyby J.

Horm Behav. 1992 Dec;26(4):545-55.

PMID:
1478638
49.

Variations in scent marking and ultrasonic vocalizations by Long-Evans rats across the estrous cycle.

Matochik JA, White NR, Barfield RJ.

Physiol Behav. 1992 Apr;51(4):783-6.

PMID:
1594676
50.

Supplemental Content

Loading ...
Support Center